Patents by Inventor Anka Veleva

Anka Veleva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12349675
    Abstract: Disclosed is a method for creating a composite colloidal particle formulation with advanced functionality that possesses highly efficient and effective properties. The composite colloidal particle formulation comprises an engineered biodegradable particle core dispersed in a bioadhesive polyelectrolyte solution. Also disclosed are methods of use of the same, including but not limited to applying said formulation to plants for disease treatment.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: July 8, 2025
    Assignee: BENANOVA INC.
    Inventor: Anka Veleva
  • Patent number: 11856948
    Abstract: Disclosed is a method for creating a composite colloidal particle formulation with advanced functionality that possesses highly efficient and effective properties. The composite colloidal particle formulation comprises an engineered biodegradable particle core dispersed in a bioadhesive polyelectrolyte solution. Also disclosed are methods of use of the same, including but not limited to applying said formulation to plants for disease treatment.
    Type: Grant
    Filed: December 16, 2021
    Date of Patent: January 2, 2024
    Assignee: BENANOVA INC.
    Inventor: Anka Veleva
  • Publication number: 20220183280
    Abstract: Disclosed is a method for creating a composite colloidal particle formulation with advanced functionality that possesses highly efficient and effective properties. The composite colloidal particle formulation comprises an engineered biodegradable particle core dispersed in a bioadhesive polyelectrolyte solution. Also disclosed are methods of use of the same, including but not limited to applying said formulation to plants for disease treatment.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 16, 2022
    Inventor: Anka Veleva
  • Publication number: 20210244022
    Abstract: Disclosed is a method for creating a composite colloidal particle formulation with advanced functionality that possesses highly efficient and effective properties. The composite colloidal particle formulation comprises an engineered biodegradable particle core dispersed in a bioadhesive polyelectrolyte solution. Also disclosed are methods of use of the same, including but not limited to applying said formulation to plants for disease treatment.
    Type: Application
    Filed: December 23, 2020
    Publication date: August 12, 2021
    Inventor: Anka Veleva
  • Patent number: 8426367
    Abstract: Provided herein are compositions and methods for binding outgrowth endothelial cells (OEC). The compositions consist of peptide ligands capable of binding OEC with high affinity and specificity. The compositions of the invention include peptides set forth in SEQ ID NO: 1-38 and variants and derivatives thereof. Compositions also include the nucleotide sequences encoding the peptides of the invention. The compositions find use in methods for the isolation of OEC and for the recruitment and retention of OEC to sites of therapeutic interest. Methods for the identification and isolation of other peptides capable of binding OEC are also provided.
    Type: Grant
    Filed: March 5, 2008
    Date of Patent: April 23, 2013
    Assignees: The University of North Carolina at Chapel Hill, North Carolina State University, The Ohio State University Research Foundation
    Inventors: Cam Patterson, Anka Veleva, Stuart Cooper
  • Publication number: 20100190703
    Abstract: Provided herein are compositions and methods for binding outgrowth endothelial cells (OEC). The compositions consist of peptide ligands capable of binding OEC with high affinity and specificity. The compositions of the invention include peptides set forth in SEQ ID NO: 1-38 and variants and derivatives thereof. Compositions also include the nucleotide sequences encoding the peptides of the invention. The compositions find use in methods for the isolation of OEC and for the recruitment and retention of OEC to sites of therapeutic interest. Methods for the identification and isolation of other peptides capable of binding OEC are also provided.
    Type: Application
    Filed: March 5, 2008
    Publication date: July 29, 2010
    Applicants: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, NORTH CAROLINA STATE UNIVERSITY, THE OHIO STATE UNIVERSITY
    Inventors: Cam Patterson, Anka Veleva, Stuart L. Cooper